尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Ferguson Toby. Officer active across 1 company, notably Voyager Therapeutics, Inc.. Cumulatively, 5 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €92k. Activity tracked since 1 April 2024. The latest transaction was filed on 6 February 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Ferguson Toby is a declarant linked to Voyager Therapeutics, Inc., where the company lists the role of Chief Medical Officer. Across 5 filings in total, the 5 most recent filings we hold run from 2024-04-03 to 2026-02-10, with 92450 EUR in sales and 0 EUR in purchases; the modal transaction nature is Attribution.